Marseille, France-based Volta Medical, an healthtech startup that works on novel Artificial Intelligence (AI) algorithms to treat cardiac arrhythmias, announced on Thursday that it has secured €36M in a Series B round of funding.
The round was led by Vensana Capital, with co-investment from Lightstone Ventures and existing investor Gilde Healthcare. The latest capital brings the total funding raised to over €70M.
The French company says it will use the funds to accelerate new product development, support additional clinical trials, prepare for full-scale US commercialisation, and pursue further regulatory approvals.
Besides funding, Volta Medical also announced the appointment of John Slump as its CFO.